Which hedge funds own PHAT? PHATHOM PHARMACEUTICALS INC, Q2 2026 13F holders
37 tracked hedge funds disclosed a position in PHAT (PHATHOM PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $318.5m in total. The largest holder by portfolio weight is Propel Bio Management, LLC at 6.0% of its book. 8 opened a new position this quarter: Jones Hill Capital LP, Opaleye Management Inc., Quantbot Technologies LP, Point72 Asset Management, L.P.. 9 exited: Catalio Capital Management, LP, Burkehill Global Management, LP, Dark Forest Capital Management LP.
- 37
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 8
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 9
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $16.6m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $7.0m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $318m
- Combined value Sum of the holders' reported positions in the security.
- 3.0%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Catalio Capital Management, LP | 0.6% | $2.8m |
| Burkehill Global Management, LP | 0.04% | $833k |
| Dark Forest Capital Management LP | 0.02% | $194k |
| Aquatic Capital Management LLC | 0.01% | $454k |
| Freestone Grove Partners LP | 0.01% | $940k |
| Tudor Investment Corp ET AL | 0.0% | $425k |
| Balyasny Asset Management L.P. | 0.0% | $1.1m |
| ExodusPoint Capital Management, LP | 0.0% | $148k |
| Schonfeld Strategic Advisors LLC | 0.0% | $173k |
Ownership over time
Who discovered PHAT first? Beta
| Saturn V Capital Management LP high conviction | Q3 2024 | +1.8 pts |
| StepStone Group LP high conviction | Q2 2025 | +1.2 pts |
| 683 Capital Management, LLC | Q3 2022 | +0.8 pts |
| Newtyn Management, LLC | Q2 2023 | +0.1 pts |
| RA Capital Management, L.P. | Q4 2019 | −0.3 pts |
| Carlyle Group Inc. high conviction | Q2 2024 | −0.4 pts |
| Summit Rock Advisors, LP | Q2 2020 | −0.4 pts |
| Opaleye Management Inc. | Q4 2022 | −0.6 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.